Does restricted pacifier use in term breastfeeding infants improve the duration of breastfeeding in lactating mothers?

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Arash Mirzaie ◽  
Timothy S. Panzer
2012 ◽  
Vol 7 (3) ◽  
pp. 1157-1179 ◽  
Author(s):  
Sharifah Halimah Jaafar ◽  
Shayesteh Jahanfar ◽  
Mubashir Angolkar ◽  
Jacqueline J Ho

2008 ◽  
Vol 8 (4) ◽  
pp. 377-389 ◽  
Author(s):  
Edson Theodoro dos Santos Neto ◽  
Adauto Emmerich Oliveira ◽  
Eliana Zandonade ◽  
Maria del Carmem Bisi Molina

This systematic review of literature proposes to establish whether pacifier use is a risk factor for a reduction in the duration of breastfeeding. A search of the Medline and Lilacs databases was carried out for articles published between 1996 and 2006 using the following descriptors: "breastfeeding" and "pacifier". Articles were excluded if they: had no open access abstracts; did not contain estimators testing the degree of association between breastfeeding duration and pacifier use; involved a follow-up loss of greater than 20%; were written in languages other than Portuguese, English and Spanish; covered specific population categories, such as pre-term babies or mothers who experienced difficulty breastfeeding; or were based on information provided by the mother or a health care professional. Nineteen articles were chosen according to the criteria outlined above; of these, one was a randomized clinical trial, eleven were prospective cohort studies and seven were cross sectional studies. The review concludes that pacifier use is a risk factor for breastfeeding duration, although the performance mechanism remains obscure. Other risk factors relate to the children, their parents and the hospital care they receive regarding the early interruption of breastfeeding. There is a need to standardize the methodology for investigating the association between pacifier use and breastfeeding duration, in order to provide scientific knowledge on this subject.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Vanessa Felipe de Deus ◽  
Erissandra Gomes ◽  
Fernanda Caramez da Silva ◽  
Elsa Regina Justo Giugliani

Author(s):  
Áurea Tamami Minagawa Toryiama ◽  
Elizabeth Fujimori ◽  
Claudia Nery Teixeira Palombo ◽  
Luciane Simões Duarte ◽  
Ana Luiza Vilela Borges ◽  
...  

ABSTRACT Objective: to analyze the changes in prevalence, median duration and correlates of breastfeeding in a small city in São Paulo state, Brazil. Method: analysis of two cross-sectional studies, conducted at intervals of one decade, with 261 and 302 children younger than two years, respectively. We used Kaplan-Meier survival analysis for calculation of the median duration of breastfeeding, and Cox regression for correlates analysis, with significance level of 5%. Results: an increase of 33.4% in the prevalence of exclusive breastfeeding and 20.9% in breastfeeding was identified. Regarding the latter, the median duration increased from 7.2 to 12 months. In the most recent study, the median duration was lower in first-born children who used pacifiers, and it was not associated with breastfeeding incentive actions. Conclusions: advances in the prevalence and duration of breastfeeding were observed during the 10 year-period, however, pacifier use still remains associated to a shorter median duration of breastfeeding. Our findings contribute to highlighting the need for intensification of nursing actions in the promotion of breastfeeding, and discouragement regarding the use of pacifiers.


Author(s):  
Sharifah Halimah Jaafar ◽  
Shayesteh Jahanfar ◽  
Mubashir Angolkar ◽  
Jacqueline J Ho

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Nadia Charepe ◽  
Juliana Gonçalves ◽  
A. Margarida Juliano ◽  
David G. Lopes ◽  
Helena Canhão ◽  
...  

Abstract Background Immunological protection via breastfeeding is well known. The immunological profile of human milk changes during lactation. No clinical trials have been conducted in lactating women with the newest mRNA vaccines against SARS- CoV-2. A Few studies have shown the presence of antibodies in breastmilk after vaccination. The aim of this work is to study possible antibodies transfer via breastmilk and also the immunological characteristics of lactating women compared to non-lactating women, after using the BNT162b2 Pfizer vaccine. Methods This is a prospective cohort study with a convenience homogenous sample of 24 healthcare workers (14 lactating and 10 non-lactating women) enrolled at the time of COVID-19 vaccination. Clinical data was registered in a questionnaire. Titers of SARS-CoV-2 spike IgG, IgA and IgM were quantified in post vaccination blood and human milk. Antibody quantification was performed by an in-house ELISA to SARS-CoV-2 trimeric spike protein. Results All women showed immunity after vaccination with positive antibodies for IgM, IgA and IgG antibodies. The dominant serum antibody response was IgG. Modest levels of antibodies in breastmilk of lactating mothers were observed in this study, especially IgG in 42.9%. There was a moderate association between higher titers of IgG and a longer duration of breastfeeding (R= 0.55, p=0.041). Conclusions Evidence of antibody transfer in human milk after COVID-19 vaccination is scarce. The presence of antibodies in human milk is reported, but immunization through breastfeeding is still to be established.


Author(s):  
Halimah Sharifah ◽  
Mubashir Angolkar ◽  
Shayesteh Jahanfar ◽  
Jacqueline J Ho

Sign in / Sign up

Export Citation Format

Share Document